SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-22-182040
Filing Date
2022-06-27
Accepted
2022-06-27 06:21:30
Documents
7

Document Format Files

Seq Description Document Type Size
1 SC14D9C d371294dsc14d9c.htm SC14D9C 17844
2 EX-99.1 d371294dex991.htm EX-99.1 50984
3 EX-99.2 d371294dex992.htm EX-99.2 10024
4 EX-99.3 d371294dex993.htm EX-99.3 8510
5 GRAPHIC g842833g0626221129703.jpg GRAPHIC 4652
6 GRAPHIC g842833g0626221130063.jpg GRAPHIC 1836
7 GRAPHIC g842833g0626221130281.jpg GRAPHIC 2368
  Complete submission text file 0001193125-22-182040.txt   101631
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filed by) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-87481 | Film No.: 221041545
SIC: 2834 Pharmaceutical Preparations